PTN — Palatin Technologies Share Price
0.000.00%
Last trade - 00:00Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.79 | ||
| Price to Tang. Book | 2.79 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 3.56 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -84.1% | ||
| Return on Equity | -378.68% | ||
| Operating Margin | -108.79% | ||
Financial Summary
| Year End 30th Jun | Unit | 2021 | 2022 | 2023 | 2024 | 2025 | 2026E | 2027E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | -0.19 | 1.47 | 4.85 | 4.49 | n/a | 11.09 | 11.67 | -100% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Palatin Technologies, Inc. is a biopharmaceutical company. The Company is engaged in developing medicines based on molecules that modulate the activity of the melanocortin receptor (MCR) system. The MCR system has effects on inflammation and immune system response, food intake, metabolism, and sexual function. Its product candidates are targeted, receptor-specific therapeutics for the treatment of diseases with unmet medical need and commercial potential. Its product development activities focus primarily on the use of MC4R agonists for treatment of obesity. It develops MC4R peptides and small molecule agonists with potential utility in obesity and metabolic-related disorders, rare MC4R pathway diseases, such as hypothalamic obesity, and orphan indications. It also develops MC1R agonist products to treat inflammatory and autoimmune diseases, such as dry eye disease, which is also known as keratoconjunctivitis sicca, uveitis, diabetic retinopathy, and inflammatory bowel disease.
Directors
- John Prendergast NEC (67)
- Carl Spana PRE (59)
- Stephen Wills CFO (64)
- Robert deVeer IND (75)
- Alan Dunton IND (67)
- Joseph Hull IND (69)
- Anthony Manning IND (59)
- Arlene Morris IND (69)
- Last Annual
- June 30th, 2025
- Last Interim
- December 31st, 2025
- Incorporated
- November 21st, 1986
- Public Since
- December 21st, 1999
- No. of Shareholders
- 50
- No. of Employees
- 29
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- NYSE MKT
- Shares in Issue
- 1,772,199
- Address
- 4-B Cedar Brook Drive, CRANBURY, 08512
- Web
- https://www.palatin.com/
- Phone
- +1 6094952200
- Auditors
- KPMG LLP
Upcoming Events for PTN
Palatin Technologies Inc Annual Shareholders Meeting
Q4 2026 Palatin Technologies Inc Earnings Release
Similar to PTN
Actinium Pharmaceuticals
NYSE MKT
Aeon Biopharma
NYSE MKT
AIM ImmunoTech
NYSE MKT
Apimeds Pharmaceuticals US
NYSE MKT
Armata Pharmaceuticals
NYSE MKT
FAQ
What is the Palatin Technologies share price?
As of Today at 22:33 UTC, shares in Palatin Technologies are trading at $18.02. This share price information is delayed by 15 minutes.
How has the Palatin Technologies share price performed this year?
Shares in Palatin Technologies last closed at $18.02 and the price had moved by -14.66% over the past 365 days. In terms of relative price strength the Palatin Technologies share price has underperformed the S&P500 Index by -32.85% over the past year.
What are the analyst and broker recommendations for Palatin Technologies?
The overall consensus recommendation for Palatin Technologies is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Palatin Technologies dividend yield?
Palatin Technologies does not currently pay a dividend.
Does Palatin Technologies pay a dividend?
Palatin Technologies does not currently pay a dividend.
When does Palatin Technologies next pay dividends?
Palatin Technologies does not currently pay a dividend.
How do I buy Palatin Technologies shares?
To buy shares in Palatin Technologies you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Palatin Technologies?
As of the previous close price of $18.02, shares in Palatin Technologies had a market capitalisation of $31.94m.
Where are Palatin Technologies shares listed?
Here are the trading details for Palatin Technologies:
- Country of listing: United States
- Exchange: ASQ
- Ticker Symbol: PTN
What kind of share is Palatin Technologies?
Based on an overall assessment of its quality, value and momentum Palatin Technologies is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Palatin Technologies share price forecast for 2026?
The analyst consensus target price for shares in Palatin Technologies is $54.33. That is 201.5% above the last closing price of $18.02.
Analysts covering Palatin Technologies currently have a consensus Earnings Per Share (EPS) forecast of -$4.24 for the next financial year.
Find out moreWhat is the trend in the Palatin Technologies share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Palatin Technologies. Over the past six months, its share price has outperformed the S&P500 Index by +143.31%.
As of the last closing price of $18.02, shares in Palatin Technologies were trading +31.86% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Palatin Technologies PE Ratio?
The Palatin Technologies PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $18.02.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Palatin Technologies?
Palatin Technologies' management team is headed by:
- John Prendergast - NEC
- Carl Spana - PRE
- Stephen Wills - CFO
- Robert deVeer - IND
- Alan Dunton - IND
- Joseph Hull - IND
- Anthony Manning - IND
- Arlene Morris - IND